I have also emailed investor relationsCan you please explain to me how Starpharmaover the past 12 years has made multiple price sensitive announcementspertaining to the Astrazeneca partnership. Updating us every step of the way.
And now, we find out that this partnership hasbeen terminated via a well-hidden figure in the AGM presentation slide deck. Ihave written to the ASX about my concerns with this.
This type of deceitful communication is onlyfurther tarnishing the fading reputation of this once promising company.
Ann: AGM Chair's address and CEO's presentation, page-20
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $41.09K | 399.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 359599 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 209650 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| SPL (ASX) Chart |